英国皇家护理学院（RCN）已终止与一家以色列制药公司的商业合作关系，理由是该公司与以色列军方存在关联。
The Royal College of Nursing (RCN) has terminated its commercial partnership with an Israeli drug company citing links with the country's military.
总部位于英国的“护士支持巴勒斯坦”组织周五称，RCN理事会主席卡梅尔·奥博伊尔向该组织证实，以色列制药企业梯瓦制药已不再获得10月30日举行的RCNi护理领导力峰会的赞助资格。
The UK-based Nurses 4 Palestine said on Friday that Carmel O’Boyle, chair of the RCN Council, confirmed to the group that Teva UK has been stripped of its sponsorship of the upcoming RCNi Nursing Leadership Summit on Oct. 30.
该组织在美国社交媒体上发布声明称，奥博伊尔在9月23日致工会的信函中公布了这一决定。声明指出：“这一决定是在多方持续呼吁后作出的——呼吁英国医疗机构停止与那些涉及以色列种族隔离及违反国际法行为的企业合作。”
O’Boyle announced the decision via its letter to the union dated Sept. 23, Nurses 4 Palestine said in a statement on US social media platform "The decision follows sustained campaigning ... demanding that UK healthcare institutions end complicity with corporate actors linked to Israeli apartheid and violations of international law," it said.
长期以来，“护士支持巴勒斯坦”组织及其他医疗从业者与工会成员一直在就这一合作事宜开展抗议活动。
Nurses 4 Palestine, UK Healthcare Petitions to the Royal Colleges healthcare professionals and union members have been campaigning about the partnership.
该组织表示，RCN方面承认，经对梯瓦制药在全球范围内的经营状况进行进一步审查，包括其受法律制裁及公众严格监督的业务领域后，认定该公司不符合护理行业的道德标准。此外，该工会还宣布将全面修订商业合作政策，并特别提及9月10日各抗议团体公开发布的联名信起到了关键作用。
The group said the RCN acknowledged that further due diligence into Teva Pharmaceuticals’ global track record, "including operations subject to legal sanctions and intense public scrutiny, found the company incompatible with the ethical standards of the nursing profession." The union also announced a full review to strengthen its commercial partnership policy, directly crediting the evidence presented in an open letter by campaigning groups on Sept. 10.
“当一线工作者团结起来，就能打破体制僵局，遏制企业的洗白行为，”‘护士支持巴勒斯坦’组织强调道。
"When frontline workers organise collectively, institutional inertia can be broken, and corporate whitewashing can be stopped," Nurses 4 Palestine said.